Drug intelligence / Profile preview

TB511R

Development stage
Preclinical
Lead developer
Twinpig Biolab
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
Administration
Intravenous
01

Overview

TB511R is a preclinical theranostic peptide-drug conjugate (PDC) developed by TwinPigBio, designed to target the tumor microenvironment. It specifically targets the active form of CD18 (Integrin beta-2) expressed on Tumor-Associated Macrophages (TAMs), particularly M2-type macrophages. Utilizing the TAMpep™ - ESCLink™ platform, TB511R is conjugated to the radioisotope Lutetium-177 (177Lu). This configuration enables a theranostic approach, where the agent can be used for both diagnostic imaging and the delivery of targeted beta-radiation to eliminate immunosuppressive TAMs, thereby enhancing anti-tumor efficacy in various cancers.

Other names
TB511R-TwinPigBio-TAM (Active CD18)-Theranostics PDC-Lutetium-177 (177Lu) radioisotope payload-Cancer
02

Targets

ITGB2 (Complement receptor 4)

Beyond the preview

Go deeper on TB511R.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TB511R.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call